Filing Flows › Prestige Consumer Healthcare (PBH) › Q2 FY27 › vs Q2 FY26
Prestige Consumer Healthcare (PBH) Q2 FY27 vs Q2 FY26 (year over year)
Prestige Consumer Healthcare's revenue rose $62.2M (+23%) from $274M in Q2 FY26 to $336M in Q2 FY27. The biggest changes: Wellness, Sleep & Other +$40.9M (+639%); Cough, Cold & Allergy +$9.0M (+33%); Dermatologicals +$8.2M (+23%). Gross margin 51.3% against 55.3% (-4.0 pts).
Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%, net earnings $25.3M, operating cash flow $37.9M. The chart draws each line against Q2 FY26, the increases inside each band.
Margins
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Gross margin | 51.3% | 55.3% | -4.0 pts |
| Operating margin | 24.0% | 29.1% | -5.1 pts |
| Net margin | 7.5% | 15.4% | -7.9 pts |
| Free cash flow margin | 10.2% | 20.2% | -10.0 pts |
Every line
| Line | Q2 FY27 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Gastrointestinal | $63.1M | $64.2M | −$1.1M | -2% |
| Women's Health | $53.6M | $52.9M | $737K | +1% |
| Wellness, Sleep & Other | $47.3M | $6.4M | $40.9M | +639% |
| Dermatologicals | $43.9M | $35.7M | $8.2M | +23% |
| Cough, Cold & Allergy | $36.3M | $27.3M | $9.0M | +33% |
| Eye & Ear Care | $34.6M | $34.2M | $436K | +1% |
| Pain Relief | $30.9M | $28.7M | $2.2M | +8% |
| Oral Care | $26.6M | $24.8M | $1.8M | +7% |
| Revenue | $336M | $274M | $62.2M | +23% |
| Gross profit | $173M | $152M | $21.0M | +14% |
| Cost of revenue | $164M | $123M | $41.2M | +34% |
| Operating profit | $80.7M | $79.7M | $1.0M | +1% |
| Operating expenses | $91.8M | $71.9M | $19.9M | +28% |
| Pre-tax earnings | $47.5M | $69.1M | −$21.7M | -31% |
| Other expense, net | $33.3M | $10.5M | $22.7M | +216% |
| Sales & marketing | $52.2M | $38.7M | $13.5M | +35% |
| General & admin | $30.9M | $28.0M | $2.9M | +10% |
| Other operating costs | $8.7M | $5.2M | $3.5M | +68% |
| Net earnings | $25.3M | $42.2M | −$16.9M | -40% |
| Income tax | $22.2M | $26.9M | −$4.8M | -18% |
| Depreciation & amortization | $12.0M | $7.7M | $4.3M | +56% |
| Share-based compensation | $1.2M | $1.8M | −$536K | -30% |
| Working capital & other | $625K | −$5.8M | $6.5M | — |
| Operating cash flow | $37.9M | $57.5M | −$19.6M | -34% |
| Free cash flow (OCF − capex) | $34.2M | $55.4M | −$21.1M | -38% |
| Capital expenditures | $3.6M | $2.1M | $1.5M | +72% |
Questions
How much did Prestige Consumer Healthcare's revenue grow year over year in Q2 FY27?
Prestige Consumer Healthcare's revenue rose $62.2M (+23%) from $274M in Q2 FY26 to $336M in Q2 FY27.
What drove Prestige Consumer Healthcare's revenue change in Q2 FY27?
Wellness, Sleep & Other +$40.9M (+639%); Cough, Cold & Allergy +$9.0M (+33%); Dermatologicals +$8.2M (+23%).